Approval · Notice of Compliance 33796 · 2024
ONDISSOLVE ODF: Notice of Compliance 33796
Issued August 12, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33796
- Date
- August 12, 2024
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM)
- Canadian reference product
- ZOFRAN ZYDIS LINGUAL (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONDISSOLVE ODF | Not yet assigned | — |
Medicinal ingredients
- ONDANSETRON 4 MG per PIECE
- ONDANSETRON 8 MG per PIECE